| Pharmaceutical active ingredients: |
| Benserazide HydrochlorideLevodopa |
| Available forms, composition and doses of Madopar T: |
| Tablets; Oral; Levodopa 100 mg; Benserazide Hydrochloride 25 mgTablets; Oral; Levodopa 200 mg; Benserazide Hydrochloride 50 mg |
| Madopar T medical category: |
| Human:Antiparkinsonian drugsMiscellaneous central nervous system agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N04BA02 - Levodopa and decarboxylase inhibitor |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Roche |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Madopar Dual Release | Benserazide Hydrochloride; Levodopa | Roche |
| Madopar GSS | Benserazide Hydrochloride; Levodopa | Roche |
| Madopar HBS | Benserazide Hydrochloride; Levodopa | Roche; DKSH; Firma Chun Cheong; Zentiva; Zuellig Pharma |
| Madopar LIQ | Benserazide Hydrochloride; Levodopa | Roche |
| Madopar LT | Benserazide Hydrochloride; Levodopa | Roche |
| Madopark | Benserazide Hydrochloride; Levodopa | Roche |
| Modopar | Benserazide Hydrochloride; Levodopa | Roche |
| Modopar Dispersible | Benserazide Hydrochloride; Levodopa | Roche |
| Modopar LP | Benserazide Hydrochloride; Levodopa | Roche |
| Pardoz | Benserazide Hydrochloride; Levodopa | Hexpharm Jaya |